Chongde Hongxin

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 4
Rounds per year 0.44
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Medical
  • Biotechnology
  • Information Services
  • Health Care
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Chongde Hongxin:
Typical Co-investors
Chongde Hongxin is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Chongde Hongxin:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ActiveHost RU Moscow, Moscow, Russia
ADAP Seed Fund 2 -
ATB Financial Alberta, Canada, Edmonton
Beijing Guohuarong Network Technology Beijing, Beijing, China
Cheshire & Warrington England, Somerset West and Taunton, United Kingdom
Claridge Canada, Montréal, Quebec
Clover Capital Partners Evanston, Illinois, United States
Edge Investments England, London, United Kingdom
Enron Investment Partners Houston, Texas, United States
Idein Ventures India, Maharashtra, Mumbai
Korea Omega Investment Seoul, Seoul-t'ukpyolsi, South Korea
Kunlun Fund China, Hangzhou, Zhejiang
Netscape California, Mountain View, United States
Redesign Health New York, New York, United States
Riverstone Energy Castel, Guernsey, Guernsey
Walker Ventures Glenwood, Maryland, United States
Wareness.io New York, New York, United States
Wildcat Venture Partners California, San Mateo, United States
Zhe Chuang Tou China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ImmuneOnco Biopharma

Biopharma
Biotechnology
Health Care
$15M11 Apr 2018 Shanghai

Information Services
Medical
31 Jan 2018 China, Dongcheng District

Biosis Healing

Biotechnology
Medical
Medical Device
$12M16 Dec 2016 Daxing, Beijing, China

Best, Inc.

Information Technology
Logistics
Public Transportation
Supply Chain Management
$10M31 Dec 2012 Shangcheng District, Zhejiang, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Chongde Hongxin?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: